• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: FARAPULSE, INC. FARAWAVE PULSED FIELD ABLATION CATHETER, 31MM; CARDIAC IRREVERSIBLE ELECTROPORATION SYSTEM CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

FARAPULSE, INC. FARAWAVE PULSED FIELD ABLATION CATHETER, 31MM; CARDIAC IRREVERSIBLE ELECTROPORATION SYSTEM CATHETER Back to Search Results
Lot Number 8011137-05
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Bradycardia (1751); Low Blood Pressure/ Hypotension (1914); Ischemia Stroke (4418)
Event Date 02/14/2024
Event Type  Injury  
Manufacturer Narrative
The device has not been received for analysis.Upon receipt and completion of the failure analysis of the complaint device, if there is any further relevant information from that review, a supplemental medwatch will be filed.
 
Event Description
Pf 106 advantage af clinical study, subject id: (b)(6).It was reported that after an irreversible electroporation ablation procedure using a farawave catheter the patient experienced ischemic cerebral vascular accident (cva).After the procedure, and prior to discharge, the patient exhibited an altered mental state.A ct scan was performed but showed no abnormalities.An mri was then taken, and physicians identified small cerebral and cerebellar ischemic infarcts.The patient was admitted to the hospital the same day, (b)(6) 2024.While in the hospital the patient was also monitored for hypotension, sinus bradycardia, and they were given norepinephrine due to hemodynamic lability they experienced during the case.Pericardial effusion was ruled out via transesophageal echocardiography.Additionally, hyperkalemia was identified during blood tests and the patient was given an insulin shot.The patient was discharged from the hospital on (b)(6) 2024.The catheter is not expected to be returned as the complication emerged after the procedure, when the catheter would have been discarded.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FARAWAVE PULSED FIELD ABLATION CATHETER, 31MM
Type of Device
CARDIAC IRREVERSIBLE ELECTROPORATION SYSTEM CATHETER
Manufacturer (Section D)
FARAPULSE, INC.
3715 haven avenue
suite 110
menlo park CA 94025
Manufacturer (Section G)
AGILE MV INC
3700 st patrick st suite 102
montreal, qc H4E 1 A2
CA   H4E 1A2
Manufacturer Contact
timothy degroot
4100 hamline avenue north
dc a330
saint paul, MN 55112
6515826168
MDR Report Key18875764
MDR Text Key337336192
Report Number2124215-2024-14478
Device Sequence Number1
Product Code QZI
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 03/11/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Lot Number8011137-05
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 02/16/2024
Initial Date FDA Received03/11/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/30/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age68 YR
Patient SexMale
Patient Weight83 KG
-
-